{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/6623d137896579001177dcbf?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Monday, April 22, 20024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1713623243022-dd7d750a1084212cd0277d22a2e533d3.jpeg?height=200","description":"<p>The Biden Administration released a final rule on the 340B Drug Pricing Program administrative dispute resolution process.&nbsp;The federal government has created a healthcare anti-trust reporting portal for the public. And a major cancer institute has retracted several research studies.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.&nbsp;</p><p><br></p>","author_name":"Gist Healthcare Daily"}